HEADER SIGNALING PROTEIN 28-NOV-19 6TKO
TITLE PHOSPHORYLATED TURKEY BETA1 ADRENOCEPTOR WITH BOUND AGONIST FORMOTEROL
TITLE 2 COUPLED TO ARRESTIN-2 IN LIPID NANODISC.
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: BETA-1 ADRENERGIC RECEPTOR;
COMPND 3 CHAIN: A;
COMPND 4 SYNONYM: BETA-1 ADRENORECEPTOR,BETA-T;
COMPND 5 ENGINEERED: YES;
COMPND 6 MUTATION: YES;
COMPND 7 OTHER_DETAILS: RELATIVE TO WILD-TYPE SEQUENCE: CONSTRUCT IS TRUNCATED
COMPND 8 AT THE N-TERMINUS; AND IN ICL3; ITS C-TERMINUS IS TRUNCATED AT C358A
COMPND 9 AND FUSED WITH A LINKER TO A SERIES OF PHOSPHORYLATED RESIDUES
COMPND 10 (ARGRPLPETGGGDE[PS]A[PT][PT]A[PS][PS][PS]LAKDTSS).;
COMPND 11 MOL_ID: 2;
COMPND 12 MOLECULE: BETA-ARRESTIN-1;
COMPND 13 CHAIN: B;
COMPND 14 SYNONYM: ARRESTIN BETA-1,NON-VISUAL ARRESTIN-2;
COMPND 15 ENGINEERED: YES;
COMPND 16 MUTATION: YES;
COMPND 17 OTHER_DETAILS: ADDITIONAL N-TERMINAL GLY RESIDUE, IN PLACE OF
COMPND 18 STARTING MET, REMAINING FROM PROTEOLYTIC CLEAVAGE.;
COMPND 19 MOL_ID: 3;
COMPND 20 MOLECULE: FAB30 HEAVY CHAIN;
COMPND 21 CHAIN: H;
COMPND 22 ENGINEERED: YES;
COMPND 23 MOL_ID: 4;
COMPND 24 MOLECULE: FAB30 LIGHT CHAIN;
COMPND 25 CHAIN: L;
COMPND 26 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: MELEAGRIS GALLOPAVO;
SOURCE 3 ORGANISM_COMMON: WILD TURKEY;
SOURCE 4 ORGANISM_TAXID: 9103;
SOURCE 5 GENE: ADRB1;
SOURCE 6 EXPRESSION_SYSTEM: TRICHOPLUSIA NI;
SOURCE 7 EXPRESSION_SYSTEM_COMMON: CABBAGE LOOPER;
SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7111;
SOURCE 9 MOL_ID: 2;
SOURCE 10 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 11 ORGANISM_COMMON: HUMAN;
SOURCE 12 ORGANISM_TAXID: 9606;
SOURCE 13 GENE: ARRB1, ARR1;
SOURCE 14 EXPRESSION_SYSTEM: ESCHERICHIA COLI;
SOURCE 15 EXPRESSION_SYSTEM_TAXID: 562;
SOURCE 16 MOL_ID: 3;
SOURCE 17 ORGANISM_SCIENTIFIC: PHAGE DISPLAY VECTOR PTDISP;
SOURCE 18 ORGANISM_TAXID: 279974;
SOURCE 19 EXPRESSION_SYSTEM: ESCHERICHIA COLI;
SOURCE 20 EXPRESSION_SYSTEM_TAXID: 562;
SOURCE 21 MOL_ID: 4;
SOURCE 22 ORGANISM_SCIENTIFIC: PHAGE DISPLAY VECTOR PTDISP;
SOURCE 23 ORGANISM_TAXID: 279974;
SOURCE 24 EXPRESSION_SYSTEM: ESCHERICHIA COLI;
SOURCE 25 EXPRESSION_SYSTEM_TAXID: 562
KEYWDS GPCR, ARRESTIN, COMPLEX, NANODISC, SIGNALING PROTEIN
EXPDTA ELECTRON MICROSCOPY
AUTHOR Y.LEE,C.G.TATE
REVDAT 4 16-OCT-24 6TKO 1 JRNL REMARK
REVDAT 3 12-AUG-20 6TKO 1 JRNL
REVDAT 2 08-JUL-20 6TKO 1 JRNL
REVDAT 1 17-JUN-20 6TKO 0
JRNL AUTH Y.LEE,T.WARNE,R.NEHME,S.PANDEY,H.DWIVEDI-AGNIHOTRI,
JRNL AUTH 2 M.CHATURVEDI,P.C.EDWARDS,J.GARCIA-NAFRIA,A.G.W.LESLIE,
JRNL AUTH 3 A.K.SHUKLA,C.G.TATE
JRNL TITL MOLECULAR BASIS OF BETA-ARRESTIN COUPLING TO
JRNL TITL 2 FORMOTEROL-BOUND BETA1-ADRENOCEPTOR.
JRNL REF NATURE V. 583 862 2020
JRNL REFN ESSN 1476-4687
JRNL PMID 32555462
JRNL DOI 10.1038/S41586-020-2419-1
REMARK 1
REMARK 1 REFERENCE 1
REMARK 1 AUTH Y.LEE,T.WARNE,R.NEHME,S.PANDEY,H.DWIVEDI-AGNIHOTRI,
REMARK 1 AUTH 2 P.C.EDWARDS,J.GARCIA-NAFRIA,A.G.W.LESLIE,A.K.SHUKLA,C.G.TATE
REMARK 1 TITL MOLECULAR DETERMINANTS OF BETA-ARRESTIN COUPLING TO
REMARK 1 TITL 2 FORMOTEROL-BOUND BETA1-ADRENOCEPTOR.
REMARK 1 REF BIORXIV 2020
REMARK 1 REFN ISSN 2692-8205
REMARK 1 DOI 10.1101/2020.03.27.011585V1
REMARK 2
REMARK 2 RESOLUTION. 3.30 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 SOFTWARE PACKAGES : SERIALEM, WARP, RELION, COOT, EPU,
REMARK 3 RELION, RELION, RELION, PHENIX, REFMAC
REMARK 3 RECONSTRUCTION SCHEMA : NULL
REMARK 3
REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT
REMARK 3 PDB ENTRY : 6IBL
REMARK 3 REFINEMENT SPACE : REAL
REMARK 3 REFINEMENT PROTOCOL : OTHER
REMARK 3 REFINEMENT TARGET : CORRELATION COEFFICIENT
REMARK 3 OVERALL ANISOTROPIC B VALUE : 80.600
REMARK 3
REMARK 3 FITTING PROCEDURE : INITIAL PLACEMENT WAS DONE MANUALLY IN COOT,
REMARK 3 FOLLOWED BY RIGID-BODY REFINEMENT IN PHENIX AND JELLY-BODY
REMARK 3 REFINEMENT IN REFMAC5. MANUAL REMODELING WAS PERFORMED IN COOT
REMARK 3 AND ITERATED WITH REAL SPACE REFINEMENT IN PHENIX. CHEMICAL
REMARK 3 RESTRAINTS FOR FORMOTEROL WERE CALCULATED IN ELBOW USING AM1
REMARK 3 OPTIMISATION.
REMARK 3
REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS
REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL
REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL
REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 3.300
REMARK 3 NUMBER OF PARTICLES : 403991
REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING AND AMPLITUDE
REMARK 3 CORRECTION
REMARK 3
REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL
REMARK 3
REMARK 3 OTHER DETAILS: HALF MAPS WERE LOCALLY FILTERED BETWEEN REFINEMENT
REMARK 3 ITERATIONS USING SIDESPLITTER, AN ADAPTATION OF THE LAFTER
REMARK 3 ALGORITHM THAT MAINTAINS GOLD-STANDARD SEPARATION BETWEEN THE
REMARK 3 TWO HALF MAPS.
REMARK 4
REMARK 4 6TKO COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 29-NOV-19.
REMARK 100 THE DEPOSITION ID IS D_1292105614.
REMARK 245
REMARK 245 EXPERIMENTAL DETAILS
REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE
REMARK 245 SPECIMEN TYPE : NULL
REMARK 245
REMARK 245 ELECTRON MICROSCOPE SAMPLE
REMARK 245 SAMPLE TYPE : PARTICLE
REMARK 245 PARTICLE TYPE : POINT
REMARK 245 NAME OF SAMPLE : FORMOTEROL-BOUND BETA1
REMARK 245 -ADRENOCEPTOR COUPLED TO BETA-
REMARK 245 ARRESTIN-1 STABILISED BY FAB30.;
REMARK 245 BETA-1 ADRENERGIC RECEPTOR;
REMARK 245 BETA-ARRESTIN-1; FAB30 HEAVY
REMARK 245 CHAIN; FAB30 LIGHT CHAIN
REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : 1.00
REMARK 245 SAMPLE SUPPORT DETAILS : NULL
REMARK 245 SAMPLE VITRIFICATION DETAILS : BLOTTED FOR 2-3 SECONDS BEFORE
REMARK 245 PLUNGING. LIQUID ETHANE
REMARK 245 MAINTAINED AT 92.15 K.
REMARK 245 SAMPLE BUFFER : NULL
REMARK 245 PH : 7.50
REMARK 245 SAMPLE DETAILS : COMPLEX FORMED IN LIPID
REMARK 245 NANODISC.
REMARK 245
REMARK 245 DATA ACQUISITION
REMARK 245 DATE OF EXPERIMENT : NULL
REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : NULL
REMARK 245 TEMPERATURE (KELVIN) : NULL
REMARK 245 MICROSCOPE MODEL : FEI TITAN KRIOS; FEI TITAN
REMARK 245 KRIOS
REMARK 245 DETECTOR TYPE : GATAN K2 QUANTUM (4K X 4K);
REMARK 245 GATAN K2 QUANTUM (4K X 4K)
REMARK 245 MINIMUM DEFOCUS (NM) : 1200.00; 1200.00
REMARK 245 MAXIMUM DEFOCUS (NM) : 3000.00; 3000.00
REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL
REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL
REMARK 245 NOMINAL CS : 2.70; 2.70
REMARK 245 IMAGING MODE : BRIGHT FIELD; BRIGHT FIELD
REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 5000.00; 4500.00
REMARK 245 ILLUMINATION MODE : FLOOD BEAM; FLOOD BEAM
REMARK 245 NOMINAL MAGNIFICATION : 105000; 130000
REMARK 245 CALIBRATED MAGNIFICATION : NULL
REMARK 245 SOURCE : FIELD EMISSION GUN; FIELD
REMARK 245 EMISSION GUN
REMARK 245 ACCELERATION VOLTAGE (KV) : 300; 300
REMARK 245 IMAGING DETAILS : DATA COLLECTED WITH A STAGE
REMARK 245 -TILT OF 30DEG; TWO NON-OVERLAPPING EXPOSURES PER HOLE AND MULTI-
REMARK 245 HOLE IMAGE-SHIFT DATA ACQUISITION STRATEGIES (3X3 HOLES PER
REMARK 245 STAGE SHIFT).; DATA COLLECTED WITH A STAGE-TILT OF 30DEG; TWO
REMARK 245 NON-OVERLAPPING EXPOSURES PER HOLE USING IMAGE-SHIFT.
REMARK 247
REMARK 247 ELECTRON MICROSCOPY
REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON
REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE
REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES
REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION
REMARK 247 OF THE STRUCTURE FACTORS.
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 TOTAL BURIED SURFACE AREA: 9400 ANGSTROM**2
REMARK 350 SURFACE AREA OF THE COMPLEX: 46370 ANGSTROM**2
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -68.0 KCAL/MOL
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, H, L
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 GLY A 32
REMARK 465 ALA A 33
REMARK 465 GLU A 34
REMARK 465 LEU A 35
REMARK 465 LEU A 36
REMARK 465 SER A 37
REMARK 465 GLN A 38
REMARK 465 GLN A 39
REMARK 465 TRP A 40
REMARK 465 GLU A 41
REMARK 465 ARG A 271
REMARK 465 ALA A 272
REMARK 465 SER A 273
REMARK 465 LYS A 274
REMARK 465 ARG A 275
REMARK 465 LYS A 276
REMARK 465 THR A 277
REMARK 465 SER A 278
REMARK 465 ARG A 279
REMARK 465 ALA A 1343
REMARK 465 ARG A 1344
REMARK 465 GLY A 1345
REMARK 465 ARG A 1346
REMARK 465 PRO A 1347
REMARK 465 LEU A 1348
REMARK 465 PRO A 1349
REMARK 465 GLU A 1350
REMARK 465 THR A 1351
REMARK 465 GLY A 1352
REMARK 465 GLY A 1353
REMARK 465 GLY A 1354
REMARK 465 ASP A 1355
REMARK 465 THR A 1369
REMARK 465 SER A 1370
REMARK 465 SER A 1371
REMARK 465 GLY B 1
REMARK 465 GLY B 2
REMARK 465 ASP B 3
REMARK 465 LYS B 4
REMARK 465 GLY B 5
REMARK 465 ARG B 331
REMARK 465 GLY B 332
REMARK 465 GLY B 333
REMARK 465 LEU B 334
REMARK 465 LEU B 335
REMARK 465 GLY B 336
REMARK 465 ASP B 337
REMARK 465 LEU B 338
REMARK 465 ALA B 339
REMARK 465 SER B 340
REMARK 465 PRO B 360
REMARK 465 PRO B 361
REMARK 465 HIS B 362
REMARK 465 ARG B 363
REMARK 465 GLU B 364
REMARK 465 VAL B 365
REMARK 465 PRO B 366
REMARK 465 GLU B 367
REMARK 465 ASN B 368
REMARK 465 GLU B 369
REMARK 465 THR B 370
REMARK 465 PRO B 371
REMARK 465 VAL B 372
REMARK 465 ASP B 373
REMARK 465 THR B 374
REMARK 465 ASN B 375
REMARK 465 LEU B 376
REMARK 465 ILE B 377
REMARK 465 GLU B 378
REMARK 465 LEU B 379
REMARK 465 ASP B 380
REMARK 465 THR B 381
REMARK 465 ASN B 382
REMARK 465 ASP B 383
REMARK 465 ASP B 384
REMARK 465 ASP B 385
REMARK 465 ILE B 386
REMARK 465 VAL B 387
REMARK 465 PHE B 388
REMARK 465 GLU B 389
REMARK 465 ASP B 390
REMARK 465 PHE B 391
REMARK 465 ALA B 392
REMARK 465 ARG B 393
REMARK 465 GLN B 394
REMARK 465 ARG B 395
REMARK 465 LEU B 396
REMARK 465 LYS B 397
REMARK 465 GLY B 398
REMARK 465 MET B 399
REMARK 465 LYS B 400
REMARK 465 ASP B 401
REMARK 465 ASP B 402
REMARK 465 LYS B 403
REMARK 465 GLU B 404
REMARK 465 GLU B 405
REMARK 465 GLU B 406
REMARK 465 GLU B 407
REMARK 465 ASP B 408
REMARK 465 GLY B 409
REMARK 465 THR B 410
REMARK 465 GLY B 411
REMARK 465 SER B 412
REMARK 465 PRO B 413
REMARK 465 GLN B 414
REMARK 465 LEU B 415
REMARK 465 ASN B 416
REMARK 465 ASN B 417
REMARK 465 ARG B 418
REMARK 465 GLU H 1
REMARK 465 ILE H 2
REMARK 465 SER H 3
REMARK 465 GLU H 4
REMARK 465 SER H 137
REMARK 465 SER H 138
REMARK 465 LYS H 139
REMARK 465 SER H 140
REMARK 465 THR H 141
REMARK 465 SER H 142
REMARK 465 GLY H 143
REMARK 465 GLY H 144
REMARK 465 THR H 145
REMARK 465 SER H 197
REMARK 465 SER H 198
REMARK 465 LEU H 199
REMARK 465 GLY H 200
REMARK 465 THR H 201
REMARK 465 GLN H 202
REMARK 465 LYS H 224
REMARK 465 SER H 225
REMARK 465 CYS H 226
REMARK 465 ASP H 227
REMARK 465 LYS H 228
REMARK 465 THR H 229
REMARK 465 HIS H 230
REMARK 465 HIS H 231
REMARK 465 HIS H 232
REMARK 465 HIS H 233
REMARK 465 HIS H 234
REMARK 465 HIS H 235
REMARK 465 HIS H 236
REMARK 465 HIS H 237
REMARK 465 GLY L 201
REMARK 465 LEU L 202
REMARK 465 SER L 203
REMARK 465 CYS L 215
REMARK 470
REMARK 470 MISSING ATOM
REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER;
REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER;
REMARK 470 I=INSERTION CODE):
REMARK 470 M RES CSSEQI ATOMS
REMARK 470 MET A 48 CG SD CE
REMARK 470 GLU A 115 CG CD OE1 OE2
REMARK 470 ILE A 177 CG1 CG2 CD1
REMARK 470 MET A 178 CG SD CE
REMARK 470 MET A 179 CG SD CE
REMARK 470 ILE A 241 CG1 CG2 CD1
REMARK 470 ASP A 242 CG OD1 OD2
REMARK 470 VAL A 280 CG1 CG2
REMARK 470 MET A 281 CG SD CE
REMARK 470 MET A 283 CG SD CE
REMARK 470 ARG A 284 CG CD NE CZ NH1 NH2
REMARK 470 GLU A 285 CG CD OE1 OE2
REMARK 470 HIS A 286 CG ND1 CD2 CE1 NE2
REMARK 470 LYS A 287 CG CD CE NZ
REMARK 470 LEU A 289 CG CD1 CD2
REMARK 470 LYS A 290 CG CD CE NZ
REMARK 470 LEU A 308 CG CD1 CD2
REMARK 470 ILE A 311 CG1 CG2 CD1
REMARK 470 VAL A 312 CG1 CG2
REMARK 470 VAL A 314 CG1 CG2
REMARK 470 ASN A 316 CG OD1 ND2
REMARK 470 ARG A 317 CG CD NE CZ NH1 NH2
REMARK 470 ASP A 318 CG OD1 OD2
REMARK 470 LEU A 319 CG CD1 CD2
REMARK 470 VAL A 320 CG1 CG2
REMARK 470 LYS A 322 CG CD CE NZ
REMARK 470 LEU A 324 CG CD1 CD2
REMARK 470 LEU A 331 CG CD1 CD2
REMARK 470 GLU A1356 CG CD OE1 OE2
REMARK 470 LYS A1367 CG CD CE NZ
REMARK 470 LYS B 17 CG CD CE NZ
REMARK 470 LYS B 49 CG CD CE NZ
REMARK 470 GLU B 92 CG CD OE1 OE2
REMARK 470 GLU B 134 CG CD OE1 OE2
REMARK 470 HIS B 159 CG ND1 CD2 CE1 NE2
REMARK 470 LEU B 191 CG CD1 CD2
REMARK 470 MET B 192 CG SD CE
REMARK 470 SER B 193 OG
REMARK 470 ASP B 194 CG OD1 OD2
REMARK 470 ASN B 311 CG OD1 ND2
REMARK 470 SER B 341 OG
REMARK 470 LYS B 357 CG CD CE NZ
REMARK 470 GLU B 358 CG CD OE1 OE2
REMARK 470 GLU B 359 CG CD OE1 OE2
REMARK 470 ASP H 65 CG OD1 OD2
REMARK 470 ASP H 154 CG OD1 OD2
REMARK 470 GLU H 158 CG CD OE1 OE2
REMARK 470 ASN H 207 CG OD1 ND2
REMARK 470 LYS H 216 CG CD CE NZ
REMARK 470 SER L 1 OG
REMARK 470 ASP L 2 CG OD1 OD2
REMARK 470 GLU L 106 CG CD OE1 OE2
REMARK 470 LYS L 127 CG CD CE NZ
REMARK 470 GLU L 214 CG CD OE1 OE2
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT
REMARK 500
REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT.
REMARK 500
REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE
REMARK 500 OG SER B 13 OD1 ASN B 15 2.08
REMARK 500 OG SER H 36 OG SER H 102 2.10
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 SER A 145 67.75 -118.93
REMARK 500 VAL H 51 -61.39 -95.65
REMARK 500 PRO H 157 -163.22 -71.10
REMARK 500 SER L 31 -169.48 -78.74
REMARK 500 ALA L 52 -5.49 72.84
REMARK 500 ASN L 159 49.64 38.65
REMARK 500
REMARK 500 REMARK: NULL
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue H98 A 2001
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC2
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide GLU A 1356 and SEP A
REMARK 800 1357
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC3
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide SEP A 1357 and ALA A
REMARK 800 1358
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC4
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide ALA A 1358 and TPO A
REMARK 800 1359
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC5
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residues TPO A 1359 and TPO A
REMARK 800 1360
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC6
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide TPO A 1360 and ALA A
REMARK 800 1361
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC7
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide ALA A 1361 and SEP A
REMARK 800 1362
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC8
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residues SEP A 1362 and SEP A
REMARK 800 1363
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC9
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residues SEP A 1363 and SEP A
REMARK 800 1364
REMARK 800
REMARK 800 SITE_IDENTIFIER: AD1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide SEP A 1364 and LEU A
REMARK 800 1365
REMARK 900
REMARK 900 RELATED ENTRIES
REMARK 900 RELATED ID: 6IBL RELATED DB: PDB
REMARK 900 6IBL CONTAINS THE SAME AGONIST-BOUND RECEPTOR COMPLEXED WITH
REMARK 900 NANOBODY NB80.
REMARK 900 RELATED ID: EMD-10515 RELATED DB: EMDB
REMARK 900 PHOSPHORYLATED TURKEY BETA1 ADRENOCEPTOR WITH BOUND AGONIST
REMARK 900 FORMOTEROL COUPLED TO ARRESTIN-2 IN LIPID NANODISC.
DBREF 6TKO A 32 357 UNP P07700 ADRB1_MELGA 32 357
DBREF 6TKO B 1 418 UNP P49407 ARRB1_HUMAN 1 418
DBREF 6TKO H 1 237 PDB 6TKO 6TKO 1 237
DBREF 6TKO L 1 215 PDB 6TKO 6TKO 1 215
SEQADV 6TKO GLY A 32 UNP P07700 SER 32 ENGINEERED MUTATION
SEQADV 6TKO CYS A 44 UNP P07700 MET 44 ENGINEERED MUTATION
SEQADV 6TKO VAL A 90 UNP P07700 MET 90 ENGINEERED MUTATION
SEQADV 6TKO CYS A 103 UNP P07700 VAL 103 ENGINEERED MUTATION
SEQADV 6TKO LEU A 116 UNP P07700 CYS 116 ENGINEERED MUTATION
SEQADV 6TKO TRP A 130 UNP P07700 GLU 130 ENGINEERED MUTATION
SEQADV 6TKO LYS A 322 UNP P07700 ASP 322 ENGINEERED MUTATION
SEQADV 6TKO ALA A 327 UNP P07700 PHE 327 ENGINEERED MUTATION
SEQADV 6TKO MET A 338 UNP P07700 PHE 338 ENGINEERED MUTATION
SEQADV 6TKO ALA A 358 UNP P07700 EXPRESSION TAG
SEQADV 6TKO ALA A 1343 UNP P07700 EXPRESSION TAG
SEQADV 6TKO ARG A 1344 UNP P07700 EXPRESSION TAG
SEQADV 6TKO GLY A 1345 UNP P07700 EXPRESSION TAG
SEQADV 6TKO ARG A 1346 UNP P07700 EXPRESSION TAG
SEQADV 6TKO PRO A 1347 UNP P07700 EXPRESSION TAG
SEQADV 6TKO LEU A 1348 UNP P07700 EXPRESSION TAG
SEQADV 6TKO PRO A 1349 UNP P07700 EXPRESSION TAG
SEQADV 6TKO GLU A 1350 UNP P07700 EXPRESSION TAG
SEQADV 6TKO THR A 1351 UNP P07700 EXPRESSION TAG
SEQADV 6TKO GLY A 1352 UNP P07700 EXPRESSION TAG
SEQADV 6TKO GLY A 1353 UNP P07700 EXPRESSION TAG
SEQADV 6TKO GLY A 1354 UNP P07700 EXPRESSION TAG
SEQADV 6TKO ASP A 1355 UNP P07700 EXPRESSION TAG
SEQADV 6TKO GLU A 1356 UNP P07700 EXPRESSION TAG
SEQADV 6TKO SEP A 1357 UNP P07700 EXPRESSION TAG
SEQADV 6TKO ALA A 1358 UNP P07700 EXPRESSION TAG
SEQADV 6TKO TPO A 1359 UNP P07700 EXPRESSION TAG
SEQADV 6TKO TPO A 1360 UNP P07700 EXPRESSION TAG
SEQADV 6TKO ALA A 1361 UNP P07700 EXPRESSION TAG
SEQADV 6TKO SEP A 1362 UNP P07700 EXPRESSION TAG
SEQADV 6TKO SEP A 1363 UNP P07700 EXPRESSION TAG
SEQADV 6TKO SEP A 1364 UNP P07700 EXPRESSION TAG
SEQADV 6TKO LEU A 1365 UNP P07700 EXPRESSION TAG
SEQADV 6TKO ALA A 1366 UNP P07700 EXPRESSION TAG
SEQADV 6TKO LYS A 1367 UNP P07700 EXPRESSION TAG
SEQADV 6TKO ASP A 1368 UNP P07700 EXPRESSION TAG
SEQADV 6TKO THR A 1369 UNP P07700 EXPRESSION TAG
SEQADV 6TKO SER A 1370 UNP P07700 EXPRESSION TAG
SEQADV 6TKO SER A 1371 UNP P07700 EXPRESSION TAG
SEQADV 6TKO GLY B 1 UNP P49407 MET 1 ENGINEERED MUTATION
SEQADV 6TKO CYS B 68 UNP P49407 LEU 68 ENGINEERED MUTATION
SEQADV 6TKO GLU B 169 UNP P49407 ARG 169 ENGINEERED MUTATION
SEQRES 1 A 328 GLY ALA GLU LEU LEU SER GLN GLN TRP GLU ALA GLY CYS
SEQRES 2 A 328 SER LEU LEU MET ALA LEU VAL VAL LEU LEU ILE VAL ALA
SEQRES 3 A 328 GLY ASN VAL LEU VAL ILE ALA ALA ILE GLY ARG THR GLN
SEQRES 4 A 328 ARG LEU GLN THR LEU THR ASN LEU PHE ILE THR SER LEU
SEQRES 5 A 328 ALA CYS ALA ASP LEU VAL VAL GLY LEU LEU VAL VAL PRO
SEQRES 6 A 328 PHE GLY ALA THR LEU VAL CYS ARG GLY THR TRP LEU TRP
SEQRES 7 A 328 GLY SER PHE LEU CYS GLU LEU TRP THR SER LEU ASP VAL
SEQRES 8 A 328 LEU CYS VAL THR ALA SER ILE TRP THR LEU CYS VAL ILE
SEQRES 9 A 328 ALA ILE ASP ARG TYR LEU ALA ILE THR SER PRO PHE ARG
SEQRES 10 A 328 TYR GLN SER LEU MET THR ARG ALA ARG ALA LYS VAL ILE
SEQRES 11 A 328 ILE CYS THR VAL TRP ALA ILE SER ALA LEU VAL SER PHE
SEQRES 12 A 328 LEU PRO ILE MET MET HIS TRP TRP ARG ASP GLU ASP PRO
SEQRES 13 A 328 GLN ALA LEU LYS CYS TYR GLN ASP PRO GLY CYS CYS ASP
SEQRES 14 A 328 PHE VAL THR ASN ARG ALA TYR ALA ILE ALA SER SER ILE
SEQRES 15 A 328 ILE SER PHE TYR ILE PRO LEU LEU ILE MET ILE PHE VAL
SEQRES 16 A 328 TYR LEU ARG VAL TYR ARG GLU ALA LYS GLU GLN ILE ARG
SEQRES 17 A 328 LYS ILE ASP ARG ALA SER LYS ARG LYS THR SER ARG VAL
SEQRES 18 A 328 MET ALA MET ARG GLU HIS LYS ALA LEU LYS THR LEU GLY
SEQRES 19 A 328 ILE ILE MET GLY VAL PHE THR LEU CYS TRP LEU PRO PHE
SEQRES 20 A 328 PHE LEU VAL ASN ILE VAL ASN VAL PHE ASN ARG ASP LEU
SEQRES 21 A 328 VAL PRO LYS TRP LEU PHE VAL ALA PHE ASN TRP LEU GLY
SEQRES 22 A 328 TYR ALA ASN SER ALA MET ASN PRO ILE ILE TYR CYS ARG
SEQRES 23 A 328 SER PRO ASP PHE ARG LYS ALA PHE LYS ARG LEU LEU ALA
SEQRES 24 A 328 ALA ARG GLY ARG PRO LEU PRO GLU THR GLY GLY GLY ASP
SEQRES 25 A 328 GLU SEP ALA TPO TPO ALA SEP SEP SEP LEU ALA LYS ASP
SEQRES 26 A 328 THR SER SER
SEQRES 1 B 418 GLY GLY ASP LYS GLY THR ARG VAL PHE LYS LYS ALA SER
SEQRES 2 B 418 PRO ASN GLY LYS LEU THR VAL TYR LEU GLY LYS ARG ASP
SEQRES 3 B 418 PHE VAL ASP HIS ILE ASP LEU VAL ASP PRO VAL ASP GLY
SEQRES 4 B 418 VAL VAL LEU VAL ASP PRO GLU TYR LEU LYS GLU ARG ARG
SEQRES 5 B 418 VAL TYR VAL THR LEU THR CYS ALA PHE ARG TYR GLY ARG
SEQRES 6 B 418 GLU ASP CYS ASP VAL LEU GLY LEU THR PHE ARG LYS ASP
SEQRES 7 B 418 LEU PHE VAL ALA ASN VAL GLN SER PHE PRO PRO ALA PRO
SEQRES 8 B 418 GLU ASP LYS LYS PRO LEU THR ARG LEU GLN GLU ARG LEU
SEQRES 9 B 418 ILE LYS LYS LEU GLY GLU HIS ALA TYR PRO PHE THR PHE
SEQRES 10 B 418 GLU ILE PRO PRO ASN LEU PRO CYS SER VAL THR LEU GLN
SEQRES 11 B 418 PRO GLY PRO GLU ASP THR GLY LYS ALA CYS GLY VAL ASP
SEQRES 12 B 418 TYR GLU VAL LYS ALA PHE CYS ALA GLU ASN LEU GLU GLU
SEQRES 13 B 418 LYS ILE HIS LYS ARG ASN SER VAL ARG LEU VAL ILE GLU
SEQRES 14 B 418 LYS VAL GLN TYR ALA PRO GLU ARG PRO GLY PRO GLN PRO
SEQRES 15 B 418 THR ALA GLU THR THR ARG GLN PHE LEU MET SER ASP LYS
SEQRES 16 B 418 PRO LEU HIS LEU GLU ALA SER LEU ASP LYS GLU ILE TYR
SEQRES 17 B 418 TYR HIS GLY GLU PRO ILE SER VAL ASN VAL HIS VAL THR
SEQRES 18 B 418 ASN ASN THR ASN LYS THR VAL LYS LYS ILE LYS ILE SER
SEQRES 19 B 418 VAL ARG GLN TYR ALA ASP ILE CYS LEU PHE ASN THR ALA
SEQRES 20 B 418 GLN TYR LYS CYS PRO VAL ALA MET GLU GLU ALA ASP ASP
SEQRES 21 B 418 THR VAL ALA PRO SER SER THR PHE CYS LYS VAL TYR THR
SEQRES 22 B 418 LEU THR PRO PHE LEU ALA ASN ASN ARG GLU LYS ARG GLY
SEQRES 23 B 418 LEU ALA LEU ASP GLY LYS LEU LYS HIS GLU ASP THR ASN
SEQRES 24 B 418 LEU ALA SER SER THR LEU LEU ARG GLU GLY ALA ASN ARG
SEQRES 25 B 418 GLU ILE LEU GLY ILE ILE VAL SER TYR LYS VAL LYS VAL
SEQRES 26 B 418 LYS LEU VAL VAL SER ARG GLY GLY LEU LEU GLY ASP LEU
SEQRES 27 B 418 ALA SER SER ASP VAL ALA VAL GLU LEU PRO PHE THR LEU
SEQRES 28 B 418 MET HIS PRO LYS PRO LYS GLU GLU PRO PRO HIS ARG GLU
SEQRES 29 B 418 VAL PRO GLU ASN GLU THR PRO VAL ASP THR ASN LEU ILE
SEQRES 30 B 418 GLU LEU ASP THR ASN ASP ASP ASP ILE VAL PHE GLU ASP
SEQRES 31 B 418 PHE ALA ARG GLN ARG LEU LYS GLY MET LYS ASP ASP LYS
SEQRES 32 B 418 GLU GLU GLU GLU ASP GLY THR GLY SER PRO GLN LEU ASN
SEQRES 33 B 418 ASN ARG
SEQRES 1 H 237 GLU ILE SER GLU VAL GLN LEU VAL GLU SER GLY GLY GLY
SEQRES 2 H 237 LEU VAL GLN PRO GLY GLY SER LEU ARG LEU SER CYS ALA
SEQRES 3 H 237 ALA SER GLY PHE ASN VAL TYR SER SER SER ILE HIS TRP
SEQRES 4 H 237 VAL ARG GLN ALA PRO GLY LYS GLY LEU GLU TRP VAL ALA
SEQRES 5 H 237 SER ILE SER SER TYR TYR GLY TYR THR TYR TYR ALA ASP
SEQRES 6 H 237 SER VAL LYS GLY ARG PHE THR ILE SER ALA ASP THR SER
SEQRES 7 H 237 LYS ASN THR ALA TYR LEU GLN MET ASN SER LEU ARG ALA
SEQRES 8 H 237 GLU ASP THR ALA VAL TYR TYR CYS ALA ARG SER ARG GLN
SEQRES 9 H 237 PHE TRP TYR SER GLY LEU ASP TYR TRP GLY GLN GLY THR
SEQRES 10 H 237 LEU VAL THR VAL SER SER ALA SER THR LYS GLY PRO SER
SEQRES 11 H 237 VAL PHE PRO LEU ALA PRO SER SER LYS SER THR SER GLY
SEQRES 12 H 237 GLY THR ALA ALA LEU GLY CYS LEU VAL LYS ASP TYR PHE
SEQRES 13 H 237 PRO GLU PRO VAL THR VAL SER TRP ASN SER GLY ALA LEU
SEQRES 14 H 237 THR SER GLY VAL HIS THR PHE PRO ALA VAL LEU GLN SER
SEQRES 15 H 237 SER GLY LEU TYR SER LEU SER SER VAL VAL THR VAL PRO
SEQRES 16 H 237 SER SER SER LEU GLY THR GLN THR TYR ILE CYS ASN VAL
SEQRES 17 H 237 ASN HIS LYS PRO SER ASN THR LYS VAL ASP LYS LYS VAL
SEQRES 18 H 237 GLU PRO LYS SER CYS ASP LYS THR HIS HIS HIS HIS HIS
SEQRES 19 H 237 HIS HIS HIS
SEQRES 1 L 215 SER ASP ILE GLN MET THR GLN SER PRO SER SER LEU SER
SEQRES 2 L 215 ALA SER VAL GLY ASP ARG VAL THR ILE THR CYS ARG ALA
SEQRES 3 L 215 SER GLN SER VAL SER SER ALA VAL ALA TRP TYR GLN GLN
SEQRES 4 L 215 LYS PRO GLY LYS ALA PRO LYS LEU LEU ILE TYR SER ALA
SEQRES 5 L 215 SER SER LEU TYR SER GLY VAL PRO SER ARG PHE SER GLY
SEQRES 6 L 215 SER ARG SER GLY THR ASP PHE THR LEU THR ILE SER SER
SEQRES 7 L 215 LEU GLN PRO GLU ASP PHE ALA THR TYR TYR CYS GLN GLN
SEQRES 8 L 215 TYR LYS TYR VAL PRO VAL THR PHE GLY GLN GLY THR LYS
SEQRES 9 L 215 VAL GLU ILE LYS ARG THR VAL ALA ALA PRO SER VAL PHE
SEQRES 10 L 215 ILE PHE PRO PRO SER ASP SER GLN LEU LYS SER GLY THR
SEQRES 11 L 215 ALA SER VAL VAL CYS LEU LEU ASN ASN PHE TYR PRO ARG
SEQRES 12 L 215 GLU ALA LYS VAL GLN TRP LYS VAL ASP ASN ALA LEU GLN
SEQRES 13 L 215 SER GLY ASN SER GLN GLU SER VAL THR GLU GLN ASP SER
SEQRES 14 L 215 LYS ASP SER THR TYR SER LEU SER SER THR LEU THR LEU
SEQRES 15 L 215 SER LYS ALA ASP TYR GLU LYS HIS LYS VAL TYR ALA CYS
SEQRES 16 L 215 GLU VAL THR HIS GLN GLY LEU SER SER PRO VAL THR LYS
SEQRES 17 L 215 SER PHE ASN ARG GLY GLU CYS
HET SEP A1357 10
HET TPO A1359 11
HET TPO A1360 11
HET SEP A1362 10
HET SEP A1363 10
HET SEP A1364 10
HET H98 A2001 25
HETNAM SEP PHOSPHOSERINE
HETNAM TPO PHOSPHOTHREONINE
HETNAM H98 ~{N}-[5-[(1~{R})-2-[[(2~{R})-1-(4-METHOXYPHENYL)PROPAN-
HETNAM 2 H98 2-YL]AMINO]-1-OXIDANYL-ETHYL]-2-OXIDANYL-
HETNAM 3 H98 PHENYL]METHANAMIDE
HETSYN SEP PHOSPHONOSERINE
HETSYN TPO PHOSPHONOTHREONINE
FORMUL 1 SEP 4(C3 H8 N O6 P)
FORMUL 1 TPO 2(C4 H10 N O6 P)
FORMUL 5 H98 C19 H24 N2 O4
HELIX 1 AA1 CYS A 44 THR A 69 1 26
HELIX 2 AA2 THR A 74 GLY A 105 1 32
HELIX 3 AA3 GLY A 110 THR A 144 1 35
HELIX 4 AA4 SER A 145 MET A 153 1 9
HELIX 5 AA5 THR A 154 HIS A 180 1 27
HELIX 6 AA6 ASP A 186 ASP A 195 1 10
HELIX 7 AA7 ASN A 204 PHE A 216 1 13
HELIX 8 AA8 PHE A 216 ASP A 242 1 27
HELIX 9 AA9 MET A 281 ASN A 316 1 36
HELIX 10 AB1 PRO A 321 CYS A 344 1 24
HELIX 11 AB2 SER A 346 ALA A 358 1 13
HELIX 12 AB3 THR B 98 GLY B 109 1 12
HELIX 13 AB4 ASN B 280 LYS B 284 5 5
HELIX 14 AB5 ARG H 90 THR H 94 5 5
HELIX 15 AB6 GLN L 80 PHE L 84 5 5
HELIX 16 AB7 SER L 122 GLY L 129 1 8
HELIX 17 AB8 LYS L 184 HIS L 190 1 7
SHEET 1 AA1 5 ALA A1361 SEP A1364 0
SHEET 2 AA1 5 ARG B 7 ALA B 12 -1 O VAL B 8 N SEP A1363
SHEET 3 AA1 5 THR B 19 LEU B 22 -1 O LEU B 22 N PHE B 9
SHEET 4 AA1 5 GLY B 39 LEU B 42 -1 O VAL B 40 N TYR B 21
SHEET 5 AA1 5 ALA B 112 PHE B 115 -1 O PHE B 115 N GLY B 39
SHEET 1 AA2 5 ASP B 26 VAL B 28 0
SHEET 2 AA2 5 ARG B 165 VAL B 171 1 O GLU B 169 N PHE B 27
SHEET 3 AA2 5 CYS B 140 ALA B 151 -1 N TYR B 144 O ILE B 168
SHEET 4 AA2 5 ARG B 52 ARG B 62 -1 N TYR B 54 O PHE B 149
SHEET 5 AA2 5 ARG B 76 PHE B 87 -1 O LYS B 77 N PHE B 61
SHEET 1 AA3 5 ASP B 26 VAL B 28 0
SHEET 2 AA3 5 ARG B 165 VAL B 171 1 O GLU B 169 N PHE B 27
SHEET 3 AA3 5 CYS B 140 ALA B 151 -1 N TYR B 144 O ILE B 168
SHEET 4 AA3 5 VAL B 127 LEU B 129 -1 N LEU B 129 O CYS B 140
SHEET 5 AA3 5 ALA B 288 ASP B 290 -1 O LEU B 289 N THR B 128
SHEET 1 AA4 4 THR B 183 THR B 187 0
SHEET 2 AA4 4 LEU B 197 LEU B 203 -1 O ALA B 201 N ALA B 184
SHEET 3 AA4 4 VAL B 220 ASN B 222 -1 O THR B 221 N HIS B 198
SHEET 4 AA4 4 SER B 266 THR B 267 -1 O SER B 266 N ASN B 222
SHEET 1 AA5 4 THR B 183 THR B 187 0
SHEET 2 AA5 4 LEU B 197 LEU B 203 -1 O ALA B 201 N ALA B 184
SHEET 3 AA5 4 ILE B 214 VAL B 218 -1 O ASN B 217 N SER B 202
SHEET 4 AA5 4 LYS B 270 LEU B 274 -1 O LEU B 274 N ILE B 214
SHEET 1 AA6 5 ILE B 207 TYR B 208 0
SHEET 2 AA6 5 ASP B 342 LEU B 351 1 O THR B 350 N TYR B 208
SHEET 3 AA6 5 VAL B 319 VAL B 329 -1 N TYR B 321 O PHE B 349
SHEET 4 AA6 5 VAL B 228 ILE B 241 -1 N SER B 234 O LYS B 324
SHEET 5 AA6 5 ALA B 247 ALA B 258 -1 O ALA B 254 N VAL B 235
SHEET 1 AA7 4 GLN H 6 SER H 10 0
SHEET 2 AA7 4 SER H 20 SER H 28 -1 O ALA H 26 N VAL H 8
SHEET 3 AA7 4 THR H 81 ASN H 87 -1 O MET H 86 N LEU H 21
SHEET 4 AA7 4 PHE H 71 ASP H 76 -1 N SER H 74 O TYR H 83
SHEET 1 AA8 5 TYR H 60 TYR H 63 0
SHEET 2 AA8 5 LEU H 48 SER H 55 -1 N SER H 55 O TYR H 60
SHEET 3 AA8 5 SER H 35 GLN H 42 -1 N TRP H 39 O VAL H 51
SHEET 4 AA8 5 ALA H 95 ARG H 103 -1 O ALA H 100 N HIS H 38
SHEET 5 AA8 5 THR H 117 VAL H 119 -1 O THR H 117 N TYR H 97
SHEET 1 AA9 4 SER H 130 LEU H 134 0
SHEET 2 AA9 4 ALA H 147 TYR H 155 -1 O LEU H 151 N PHE H 132
SHEET 3 AA9 4 TYR H 186 THR H 193 -1 O VAL H 192 N LEU H 148
SHEET 4 AA9 4 HIS H 174 THR H 175 -1 N HIS H 174 O VAL H 191
SHEET 1 AB1 4 SER H 130 LEU H 134 0
SHEET 2 AB1 4 ALA H 147 TYR H 155 -1 O LEU H 151 N PHE H 132
SHEET 3 AB1 4 TYR H 186 THR H 193 -1 O VAL H 192 N LEU H 148
SHEET 4 AB1 4 VAL H 179 LEU H 180 -1 N VAL H 179 O SER H 187
SHEET 1 AB2 3 THR H 161 TRP H 164 0
SHEET 2 AB2 3 ILE H 205 HIS H 210 -1 O ASN H 207 N SER H 163
SHEET 3 AB2 3 THR H 215 LYS H 220 -1 O VAL H 217 N VAL H 208
SHEET 1 AB3 4 MET L 5 SER L 8 0
SHEET 2 AB3 4 VAL L 20 ALA L 26 -1 O ARG L 25 N THR L 6
SHEET 3 AB3 4 ASP L 71 ILE L 76 -1 O LEU L 74 N ILE L 22
SHEET 4 AB3 4 PHE L 63 ARG L 67 -1 N SER L 64 O THR L 75
SHEET 1 AB4 2 SER L 11 ALA L 14 0
SHEET 2 AB4 2 LYS L 104 ILE L 107 1 O GLU L 106 N ALA L 14
SHEET 1 AB5 4 SER L 54 LEU L 55 0
SHEET 2 AB5 4 PRO L 45 TYR L 50 -1 N TYR L 50 O SER L 54
SHEET 3 AB5 4 ALA L 35 GLN L 39 -1 N GLN L 38 O LYS L 46
SHEET 4 AB5 4 THR L 86 GLN L 90 -1 O THR L 86 N GLN L 39
SHEET 1 AB6 4 SER L 115 PHE L 119 0
SHEET 2 AB6 4 THR L 130 PHE L 140 -1 O ASN L 138 N SER L 115
SHEET 3 AB6 4 TYR L 174 SER L 183 -1 O LEU L 182 N ALA L 131
SHEET 4 AB6 4 SER L 160 THR L 165 -1 N THR L 165 O SER L 175
SHEET 1 AB7 4 LEU L 155 GLN L 156 0
SHEET 2 AB7 4 LYS L 146 LYS L 150 -1 N TRP L 149 O GLN L 156
SHEET 3 AB7 4 VAL L 192 THR L 198 -1 O THR L 198 N LYS L 146
SHEET 4 AB7 4 VAL L 206 ASN L 211 -1 O VAL L 206 N VAL L 197
SSBOND 1 CYS A 44 CYS A 103 1555 1555 2.03
SSBOND 2 CYS A 114 CYS A 199 1555 1555 2.03
SSBOND 3 CYS A 192 CYS A 198 1555 1555 2.03
SSBOND 4 CYS H 25 CYS H 99 1555 1555 2.03
SSBOND 5 CYS H 150 CYS H 206 1555 1555 2.03
SSBOND 6 CYS L 24 CYS L 89 1555 1555 2.03
SSBOND 7 CYS L 135 CYS L 195 1555 1555 2.03
LINK C GLU A1356 N SEP A1357 1555 1555 1.33
LINK C SEP A1357 N ALA A1358 1555 1555 1.33
LINK C ALA A1358 N TPO A1359 1555 1555 1.33
LINK C TPO A1359 N TPO A1360 1555 1555 1.33
LINK C TPO A1360 N ALA A1361 1555 1555 1.33
LINK C ALA A1361 N SEP A1362 1555 1555 1.33
LINK C SEP A1362 N SEP A1363 1555 1555 1.33
LINK C SEP A1363 N SEP A1364 1555 1555 1.33
LINK C SEP A1364 N LEU A1365 1555 1555 1.33
CISPEP 1 PHE B 87 PRO B 88 0 -0.64
CISPEP 2 PHE H 105 TRP H 106 0 -4.17
CISPEP 3 PHE H 156 PRO H 157 0 -0.57
CISPEP 4 SER L 8 PRO L 9 0 -1.64
CISPEP 5 VAL L 95 PRO L 96 0 0.44
CISPEP 6 TYR L 141 PRO L 142 0 0.01
SITE 1 AC1 13 ASP A 121 VAL A 125 ASP A 200 PHE A 201
SITE 2 AC1 13 SER A 211 SER A 215 PHE A 306 PHE A 307
SITE 3 AC1 13 ASN A 310 PHE A 325 VAL A 326 ASN A 329
SITE 4 AC1 13 TYR A 333
SITE 1 AC2 5 ALA A1358 TPO A1359 LYS B 11 PRO B 14
SITE 2 AC2 5 ARG B 165
SITE 1 AC3 6 GLU A1356 TPO A1359 TPO A1360 LYS B 11
SITE 2 AC3 6 ALA B 12 ARG B 165
SITE 1 AC4 8 GLU A1356 SEP A1357 TPO A1360 ALA A1361
SITE 2 AC4 8 LYS B 11 ALA B 12 LYS B 294 HIS B 295
SITE 1 AC5 8 SEP A1357 ALA A1358 ALA A1361 LYS B 11
SITE 2 AC5 8 ARG B 25 LEU B 166 LYS B 294 HIS B 295
SITE 1 AC6 9 ALA A1358 TPO A1359 SEP A1362 PHE B 9
SITE 2 AC6 9 LYS B 10 LYS B 11 ARG B 25 LEU B 166
SITE 3 AC6 9 LYS B 294
SITE 1 AC7 9 TPO A1359 TPO A1360 SEP A1363 ARG B 7
SITE 2 AC7 9 VAL B 8 PHE B 9 LYS B 10 SER L 31
SITE 3 AC7 9 ARG L 67
SITE 1 AC8 9 ALA A1361 SEP A1364 LEU A1365 ARG B 7
SITE 2 AC8 9 VAL B 8 LYS B 10 LYS B 107 SER L 31
SITE 3 AC8 9 ARG L 67
SITE 1 AC9 6 SEP A1362 LEU A1365 ARG B 7 VAL B 8
SITE 2 AC9 6 LYS B 10 LYS B 107
SITE 1 AD1 7 SEP A1363 ALA A1366 LYS A1367 THR B 6
SITE 2 AD1 7 ARG B 7 ARG B 103 LYS B 107
CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 1.000000 0.000000 0.000000 0.00000
SCALE2 0.000000 1.000000 0.000000 0.00000
SCALE3 0.000000 0.000000 1.000000 0.00000